Whalesbook
Operational Push Meets Cost Headwinds
Ambuja Cements is highlighting profitable growth and operational efficiencies at its Sanghipuram plant, with management expressing confidence in margin stabilization and strong demand. However, this focus on internal improvements faces significant challenges from rising input costs and recent financial results, suggesting a complex outlook for investors.
Stock Dip Despite Plant Visits
Ambuja Cements' stock saw a brief rise of over 3% on March 10, 2026, after analysts visited its Sanghipuram plant and heard positive updates. Management stressed cost reduction, premium product sales, and potential capacity expansion to boost margins. The company aims for 115 million tonnes per annum (mtpa) capacity by FY26 and 155 mtpa by FY28. Despite these efforts, the stock is down about 18% year-to-date, reflecting investor skepticism about immediate prospects.
Industry Faces Demand-Cost Squeeze
The cement industry is experiencing robust demand growth, projected at 6-7% for FY26, driven by infrastructure and housing projects. However, this positive demand is challenged by rapidly escalating operational costs. Geopolitical issues have pushed Brent crude oil prices towards $120 per barrel, significantly raising the cost of imported pet coke and coal. For Ambuja Cements, fuel and power, which account for 30-35% of production costs, are a major concern. While the company holds 30-45 days of fuel inventory for a buffer, margin erosion is likely if these cost pressures continue.
Analyst Concerns and Profit Plunge
The optimistic outlook from some analysts, including 'Buy' ratings from Jefferies (target ₹735) and Centrum Broking (target ₹653), is challenged by stark financial results and bearish views. Ambuja Cements' Q3 FY26 net profit plunged 90.6% year-on-year to ₹204 crore, with quarterly profit after tax (PAT) falling 89.9%. This indicates severe margin compression despite revenue growth. MarketsMojo issued a 'Strong Sell' rating in late January 2026, citing weak long-term growth, declining operating profit, and bearish technicals. Nuvama significantly reduced its EBITDA estimates and target price due to geopolitical issues and rising pet coke prices.
Valuation and Long-Term Ambitions
Ambuja Cements' P/E ratio of 30.8x is currently below the industry average of about 36.07x. However, its valuation and recent performance trail key competitors like UltraTech Cement, which shows higher market capitalization and stronger growth. UltraTech's P/E is higher, ranging from 43.61x to over 55x, while Shree Cement trades at even higher multiples. Despite these comparisons, Ambuja's long-term strategy includes significant capacity expansion and a proposed merger with ACC and Orient Cement.
Outlook Mixed Amid Merger Plans
Looking ahead, some brokerages like Motilal Oswal maintain a 'Buy' rating (target ₹600), and ICICI Securities rates it 'Add' (target ₹540). However, the near-term outlook is uncertain due to volatile input costs and execution risks. A key development is the proposed merger into a 'One Cement Platform,' pending regulatory approval, which could reshape the industry. Investors will be watching closely to see if Ambuja Cements can achieve sustained margin improvement amidst high costs and successfully integrate its expansion and consolidation plans.